Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Genetics
|
May 5, 2012
Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus)
Guy M L Perry, Keith W Nehrke, David A Bushinsky, et al.
American Journal of Nephrology
|
October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
David A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Kidney International
|
February 19, 2002
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats
David A Bushinsky, John R Asplin, Marc D Grynpas, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2003
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease
L Darryl Quarles, Donald J Sherrard, Stephen Adler, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria
Nancy S Krieger, John R Asplin, Kevin K Frick, et al.
Kidney International Reports
|
July 19, 2019
Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
John Cunningham, Geoffrey A Block, Glenn M Chertow, et al.
European Journal of Heart Failure
|
October 14, 2015
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
Bertram Pitt, George L Bakris, David A Bushinsky, et al.
The American Journal of Medicine
|
November 29, 2017
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors
Matthew R Weir, David A Bushinsky, Wade W Benton, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 6, 2017
Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD
David A Bushinsky, Thomas Hostetter, Gerrit Klaerner, et al.
JAMA
|
July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
George L Bakris, Bertram Pitt, Matthew R Weir, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Genetics
|
May 5, 2012
Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus)
Guy M L Perry, Keith W Nehrke, David A Bushinsky, et al.
American Journal of Nephrology
|
October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
David A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Kidney International
|
February 19, 2002
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats
David A Bushinsky, John R Asplin, Marc D Grynpas, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2003
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease
L Darryl Quarles, Donald J Sherrard, Stephen Adler, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria
Nancy S Krieger, John R Asplin, Kevin K Frick, et al.
Kidney International Reports
|
July 19, 2019
Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
John Cunningham, Geoffrey A Block, Glenn M Chertow, et al.
European Journal of Heart Failure
|
October 14, 2015
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
Bertram Pitt, George L Bakris, David A Bushinsky, et al.
The American Journal of Medicine
|
November 29, 2017
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors
Matthew R Weir, David A Bushinsky, Wade W Benton, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 6, 2017
Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD
David A Bushinsky, Thomas Hostetter, Gerrit Klaerner, et al.
JAMA
|
July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
George L Bakris, Bertram Pitt, Matthew R Weir, et al.
Page
of 13